MAJI (Exousia Pro) EBIT per Share: $-0.04 (TTM As of Jan. 2021)


What is Exousia Pro EBIT per Share?

Exousia Pro MAJI +3.45% EBIT per Share is $-0.04 as of Jan. 2021.

Exousia Pro's EBIT per Share for the three months ended in Jan. 2021 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2021 was $-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Exousia Pro's EBIT per Share or its related term are showing as below:

MAJI's 3-Year EBIT Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 15.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Exousia Pro's EBIT for the three months ended in Jan. 2021 was $-0.13 Mil.

Exousia Pro  (OTCPK:MAJI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Exousia Pro EBIT per Share Related Terms

Exousia Pro EBIT per Share Historical Data

* Premium members only.

The historical data trend for Exousia Pro's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro EBIT per Share Chart

Exousia Pro Annual Data
Trend Apr11 Apr12 Apr18 Apr19
EBIT per Share
-0.02 -1.78 0.00 -0.01

Exousia Pro Quarterly Data
Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.01 -0.01 -0.01

Exousia Pro EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Exousia Pro's EBIT per Share for the fiscal year that ended in Apr. 2019 is calculated as

EBIT per Share(A: Apr. 2019 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.125/12.489
=-0.01

Exousia Pro's EBIT per Share for the quarter that ended in Jan. 2021 is calculated as

EBIT per Share(Q: Jan. 2021 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.134/13.515
=-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.04 mean?
Exousia Pro (MAJI) has a EBIT per Share of $-0.04 as of Jan. 2021. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Exousia Pro and its competitors.
Is Exousia Pro's EBIT per Share too high?
Exousia Pro's current EBIT per Share is $-0.04.
How does Exousia Pro's EBIT per Share compare to HCCH and GRNV?
Exousia Pro's EBIT per Share of $-0.04 can be compared against companies in the Biotechnology industry. The industry median EBIT per Share is 15.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.40, based on 1,172 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Exousia Pro and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exousia Pro's current EBIT per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exousia Pro stock overvalued right now?
Exousia Pro (MAJI) has a current EBIT per Share of $-0.04. The current EBIT per Share is $-0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Exousia Pro (MAJI), the current EBIT per Share is $-0.04 as of Jan. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.